In clinical trials, medications such as semaglutide, liraglutide, and tirzepatide consistently produce significant weight loss
Skeletal muscle shows the most dramatic responses
We present a detailed picture showing that epithelial-to-mesenchymal transition, cancer metabolic reprogramming, alterations in important signalling pathways, epigenetic aberrations and the tumour microenvironment are crucial drivers of PTC metastasis
If a patient is interested in BPC-157, the discussion should include why they are interested, what condition they are trying to address, what has already been diagnosed, what other treatments have been tried, what medications they take, and what safety questions apply
Structural basis for the binding of the anticancer compound 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol to human glutathione s-transferases